Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases

Abstract

Due to a fast decline in anti-RBD antibodies in IMID patients an early 4^th vaccination should be considered in this vulnerable group of patients.